Reading Dwayne, Burmeister Bryan
GenesisCare Radiation Oncology, St Stephens Hospital, Urraween, Queensland, Australia.
University of Queensland, Rural Clinical School, Urraween, Queensland, Australia.
Case Rep Gastroenterol. 2022 May 30;16(2):333-338. doi: 10.1159/000524530. eCollection 2022 May-Aug.
Malignant tracheo-oesophageal fistula (TEF) can result from tumour progression and invasion of adjacent organs, or a complication of treatment. In the posttreatment setting, incidence of TEF in cases with preceding airway invasion (T4b) are not infrequently reported; however, for those for whom disease was confined to organ (T1-3) at staging, this is a rare complication. Management for these cases is palliative in nature, with the goal to prevent aspiration by closing the connection and facilitate safe resumption of oral intake where possible. Herein we report a case of a 71-year-old female with a T3 oesophageal squamous cell carcinoma, who presented with new onset dysphagia 2 weeks after completing a course of definitive radiotherapy and was found to have a broncho-oesophageal fistula. This patient was managed with dual stenting of both the airway and oesophagus, an emerging management option for this condition, and was thereafter able to safely resume oral intake.
恶性气管食管瘘（TEF）可由肿瘤进展和侵犯相邻器官引起，或为治疗的并发症。在治疗后的情况下，先前存在气道侵犯（T4b）的病例中TEF的发生率并不少见；然而，对于那些在分期时疾病局限于器官（T1-3）的患者，这是一种罕见的并发症。这些病例的治疗本质上是姑息性的，目标是通过封闭连接来防止误吸，并在可能的情况下促进安全恢复经口进食。在此，我们报告一例71岁女性，患有T3期食管鳞状细胞癌，在完成一个疗程的根治性放疗后2周出现新发吞咽困难，经检查发现有支气管食管瘘。该患者接受了气道和食管双支架置入治疗，这是针对这种情况的一种新兴治疗选择，此后能够安全地恢复经口进食。
